IL6 and pancreatic neoplasm: Studies have shown that, in pancreatic cancer models, ω6-PUFAs have antitumor activity and inhibit the continuous growth of pancreatic tumors, ω6-PUFAs inhibits the proliferation of prostate cancer cells and regulates inflammatory IL-6 and TNF by affecting the production of cytokines-α [163].